UA110280C2 - Micellar composition for delivery of cancer drugs - Google Patents
Micellar composition for delivery of cancer drugsInfo
- Publication number
- UA110280C2 UA110280C2 UAA201405945A UAA201405945A UA110280C2 UA 110280 C2 UA110280 C2 UA 110280C2 UA A201405945 A UAA201405945 A UA A201405945A UA A201405945 A UAA201405945 A UA A201405945A UA 110280 C2 UA110280 C2 UA 110280C2
- Authority
- UA
- Ukraine
- Prior art keywords
- delivery
- micellar
- anticancer drug
- polyethyleneoa
- cooh
- Prior art date
Links
- 239000003560 cancer drug Substances 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 3
- 229940041181 antineoplastic drug Drugs 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 229920000359 diblock copolymer Polymers 0.000 abstract 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 abstract 1
- 229920002401 polyacrylamide Polymers 0.000 abstract 1
- 229920000428 triblock copolymer Polymers 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Винахід стосується міцелярної композиції для доставки протиракового препарату, що як міцелярні носії протиракового препарату містить частково гідролізовані подвійні гідрофільні диблок- або триблок-кополімери (ДБК-СООН або ТБК-СООН) поліакриламіду та метоксиполіетиленоксиду або поліетиленоксиду (МОПЕО--ПАА або ПАА--ПЕО--ПАА) з хімічно комплементарними блоками різної довжини, які утворюють інтрамолекулярні полікомплекси та міцелярні структури моно- і полімолекулярного типів, а як протираковий препарат містить гідрохлорид доксорубіцину.The invention relates to a micellar composition for the delivery of an anticancer drug, which as a micellar carrier of the anticancer drug contains partially hydrolyzed double hydrophilic diblock or triblock copolymers (DBK-COOH or TBK-COOH) polyacrylamide and methoxypolyethyleneOA or polyethyleneOA or polyethyleneOA - PAA) with chemically complementary blocks of different lengths, forming intramolecular polycomplexes and micellar structures of mono- and polymolecular types, and containing doxorubicin hydrochloride as an anticancer drug in.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201405945A UA110280C2 (en) | 2014-05-30 | 2014-05-30 | Micellar composition for delivery of cancer drugs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201405945A UA110280C2 (en) | 2014-05-30 | 2014-05-30 | Micellar composition for delivery of cancer drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA110280C2 true UA110280C2 (en) | 2015-12-10 |
Family
ID=55171491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201405945A UA110280C2 (en) | 2014-05-30 | 2014-05-30 | Micellar composition for delivery of cancer drugs |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA110280C2 (en) |
-
2014
- 2014-05-30 UA UAA201405945A patent/UA110280C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123953T1 (en) | DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE | |
| EA201790024A1 (en) | MODULATORS OF TOLL-LIKE RECEPTORS FOR HIV TREATMENT | |
| EP3331547A4 (en) | COMPOSITIONS HAVING PERMEATION AMPLIFIERS FOR DRUG ADMINISTRATION | |
| EP3315608A4 (en) | Sirna, pharmaceutical composition and conjugate which contain sirna, and uses thereof | |
| MA41265A (en) | COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS. | |
| WO2014153030A3 (en) | Methods of treating cancer and preventing cancer drug resistance | |
| MX389178B (en) | FIXED RATIO FORMULATION OF INSULIN GLARGINE/LIXISENATIDE. | |
| CY1121999T1 (en) | PHARMACEUTICAL FORMS OF DARUNAVIR COMBINATION | |
| UA116889C2 (en) | COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS | |
| TR201821116A2 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING POSACONAZOL AND THE MANUFACTURING METHOD | |
| EA201791454A1 (en) | DRUG FORMS FOR TRANSDERMAL ADMINISTRATION | |
| CY1119446T1 (en) | PHARMACEUTICAL FORMS DARUNAVIRIS | |
| MX2016011938A (en) | Liquid pharmaceutical composition. | |
| CY1125583T1 (en) | PHARMACEUTICAL FORM OF ATAZANAVIR AND COBICISTAT FOR HIV TREATMENT | |
| MX389026B (en) | A PHARMACEUTICAL COMPOSITION AND ITS USE. | |
| MX387731B (en) | ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE. | |
| EA201791600A1 (en) | DERIVATIVES OF HYDROXIALKILPIPERASINE AS RECESSOR CXCR3 MODULATORS | |
| CY1122080T1 (en) | [2,3-C]PYRIDINE 7-(MORPHOLINYL)-2-(N-PIPERAZINYL) METHYL THIATE AS ANTICANCER DRUGS | |
| EP3213746A4 (en) | Pharmaceutical composition for oral administration comprising taxane | |
| EA201991287A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE | |
| EA201400444A1 (en) | DERIVATIVES 2-OXOPYPERIDINYL | |
| EP3564224A3 (en) | Crystalline form of vortioxetine hydrobromide as antidepressant drug | |
| LT4056557T (en) | BENZAZEPINE DERIVATIVES USED AS DRUGS | |
| DK3453390T3 (en) | PHARMACEUTICAL COMPOSITION CONTAINING POLYMERIZED DRUG | |
| HK1258512A1 (en) | Prodrugs of fencamfamine |